Market revenue in 2023 | USD 32.1 million |
Market revenue in 2030 | USD 70.0 million |
Growth rate | 11.8% (CAGR from 2023 to 2030) |
Largest segment | Laboratory testing |
Fastest growing segment | Laboratory Testing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Laboratory Testing |
Key market players worldwide | Alcami, Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc, Charles River Laboratories International Inc, Catalent Inc, Avomeen Analytical Services, Pace Analytical Services, Sotera Health Co Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceuticals manufacturing consumables testing market will help companies and investors design strategic landscapes.
Laboratory testing was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the Latin America biopharmaceuticals manufacturing consumables testing market based on laboratory testing covering the revenue growth of each sub-segment from 2018 to 2030.
In the last decade, the Latin American regulatory agencies have evolved considerably due to growing requirement for pharmaceutical product safety and efficacy standards. Pan American Network for Drug Regulatory Harmonization initiative by Pan American Health Organization aimed at improving the pharmaceutical landscape in the region through various strategies.
With Brazil on the forefront, Latin American market is expected to emerge as a promising market in the foreseeable future. This can be attributed to the improvement in the manufacturing capacity of domestic companies and the growing demand.
Furthermore, it is believed that in the future, biologics and biosimilars would be a major part of the Argentinian pharmaceutical market. These factors are anticipated to significantly impact the adoption of testing services for biologics manufacturing; however, the poorly defined regulatory guidelines, especially about biosimilars, are expected to negatively impact the market to some extent.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America biopharmaceuticals manufacturing consumables testing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America biopharmaceuticals manufacturing consumables testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account